🇺🇸 Oxybutynin Pill in United States

5 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 5

Most-reported reactions

1. Dry Mouth — 1 report (20%)
2. Fatigue — 1 report (20%)
3. Product Administered At Inappropriate Site — 1 report (20%)
4. Therapy Non-Responder — 1 report (20%)
5. Vision Blurred — 1 report (20%)

Source database →

Frequently asked questions

Is Oxybutynin Pill approved in United States?

Oxybutynin Pill does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Oxybutynin Pill in United States?

Universidad de Valparaiso is the originator. The local marketing authorisation holder may differ — check the official source linked above.